Antiretroviral treatment in resource-poor settings: clinical research priorities
- 1 November 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9344) , 1503-1505
- https://doi.org/10.1016/s0140-6736(02)11478-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral LoadJAMA, 2001
- Comparative Assessment of Five Alternative Methods for CD4+ T-Lymphocyte Enumeration for Implementation in Developing CountriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Hit HIV-1 hard, but only when necessaryThe Lancet, 2000
- Human Immunodeficiency Virus Type 1 p24 Concentration Measured by Boosted ELISA of Heat‐Denatured Plasma Correlates with Decline in CD4 Cells, Progression to AIDS, and Survival: Comparison with Viral RNA MeasurementThe Journal of Infectious Diseases, 2000
- Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance TherapyJAMA, 2000
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- A Whole Blood Alternative to Traditional Methods for CD4+ T Lymphocyte DeterminationJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- CD4 and total lymphocyte counts as predictors of HIV disease progressionQJM: An International Journal of Medicine, 1996